Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression

Haematologica
Alexandre GuyChloe James

Abstract

Thrombosis is the main cause of morbidity and mortality in patients with JAK2V617F myeloproliferative neoplasms. Recent studies have reported the presence of JAK2V617F in endothelial cells of some patients with myeloproliferative neoplasms. We investigated the role of endothelial cells that express JAK2V617F in thrombus formation using an in vitro model of human endothelial cells overexpressing JAK2V617F and an in vivo model of mice with endothelial-specific JAK2V617F expression. Interestingly, these mice displayed a higher propensity for thrombus. When deciphering the mechanisms by which JAK2V617F-expressing endothelial cells promote thrombosis, we observed that they have a pro-adhesive phenotype associated with increased endothelial P-selectin exposure, secondary to degranulation of Weibel-Palade bodies. We demonstrated that P-selectin blockade was sufficient to reduce the increased propensity of thrombosis. Moreover, treatment with hydroxyurea also reduced thrombosis and decreased the pathological interaction between leukocytes and JAK2V617F-expressing endothelial cells through direct reduction of endothelial P-selectin expression. Taken together, our data provide evidence that JAK2V617F-expressing endothelial cells promote ...Continue Reading

Citations

Sep 19, 2019·Médecine sciences : M/S·Alexandre Guy, Chloé James
Oct 18, 2019·Genes·Lucie LanikovaJosef T Prchal
Jul 30, 2020·International Journal of Molecular Sciences·Maria A Lizarralde-Iragorri, Arun S Shet
Jul 2, 2019·Frontiers in Immunology·Cecilia P Marin Oyarzún, Paula G Heller
Apr 9, 2020·Journal of Thrombosis and Thrombolysis·Michaël LevrautNihal Martis
Mar 27, 2020·Research and Practice in Thrombosis and Haemostasis·Monica SaccoRaimondo De Cristofaro
Sep 14, 2020·Journal of Thrombosis and Haemostasis : JTH·Melissa CastiglioneHuichun Zhan
Feb 16, 2021·Hämostaseologie·Anna FalangaFrancesca Schieppati
Mar 2, 2021·Hematology/oncology Clinics of North America·Douglas TremblayRonald Hoffman
Mar 2, 2021·Hematology/oncology Clinics of North America·Karie Chen, Alan H Shih
Mar 2, 2021·Hematology/oncology Clinics of North America·Andrew I Schafer
Apr 21, 2021·Current Hematologic Malignancy Reports·Brandi N Reeves, Joan D Beckman
Apr 22, 2021·HemaSphere·Andrew J Robinson, Anna L Godfrey
Feb 6, 2020·La Revue de médecine interne·C MornetE Lippert
Aug 18, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anish V ShardaJeffrey I Zwicker
Dec 24, 2021·Expert Review of Hematology·Nabin Raj KarkiAbdullah Kutlar

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

FIJI Image J
ZEN

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.